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Why are we talking about this? 
• Use of commercially available product 
for an IDE trial -  identical device may be 
on the shelf (sloppy)   
 
 
• Use of an IDE product outside of the trial 
(temptation) 
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Purpose of Device Accountability 
• Both misuses create real problems 
• Protect the rights, safety and welfare of 
research subjects and patients by 
ensuring the control and accountability of  
investigational devices used in clinical 
research 
• Protect data integrity 
– Safety and efficacy or substantial 
equivalency cannot be established if study 
devices not used 
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Consequences 
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Investigator Responsibilities 
• Control of the investigational device used in 
the study  
• Ensure the device is stored in a secure area 
• Ensure device is used only in patients that 
consented to participate in the trial 
• Ensure device is used according to the IRB-
approved protocol 
• Ensure records related to the receipt, use 
and disposition of the device are adequately 
maintained 
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Receipt and Inventory  
 Inventory typically shipped to coordinator 
Upon receipt of the investigational device 
inventory the shipment, confirm the information 





 If a discrepancy is noted, contact the sponsor 
immediately and return any damaged, defective or 
discrepant devices 
 File packing slip in the device binder 
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Device accountability log 
Once the inventory is complete and 
confirmed, enter the data into the device log 
including: 
1.Date of receipt 
2.Serial and/or lot number 
3.Expiration date 
4.Name or identifiers of person who receives 
device  
5.Ensure all entries are legible.  
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Site Name: Washington University School of Medicine 
Site Number: 1234 
Principal Investigator: Fred Stent, MD 
 
TO THE INVESTIGATOR: 
1.  PLEASE MAINTAIN THIS LOG THROUGHOUT THE STUDY.  EACH TEST ARTICLE MUST BE ITEMIZED INDIVIDUALLY BELOW. 
2.  ALL DEVICES RECEIVED BY THE INSTITUTION OR INVESTIGATOR MUST BE ACCOUNTED FOR WHETHER USED OR NOT. 
3.  AT THE COMPLETION OF THE STUDY, PLEASE RETURN ANY UNUSED DEVICES TO THE ADDRESS SHOWN BELOW:  
 Stent Company 
        1234 Stent Street 
        Stent Town, MO 12345 














D = DISCARDED  
R = RETURNED TO SPONSOR 
I  = Implanted  
DISPOSITION DATE 







(EXPLAIN IF DEVICE WAS DISCARDED, 
RETURNED TO SPONSOR OR OTHER 





4.0 x 12 












3.5 x 16 











2.5 x 22 















  N/A 
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Device accountability log 
Storage of Device 
• Store investigational device in a secure 
location with access limited to the 
essential research personnel 
• Device must be kept in a locked closet or 
cabinet 
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Storage of Device 
NO  YES  
Dispensing Devices  
Each time a device is dispensed by the 
Investigator or a member of the research 
team, the device log must be updated.  
This includes: 
1.Device disposition 
2.Date of disposition 
3.Patient study number  
4.Initials of individual dispensing 
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 D       
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  N/A 
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Dispensing Devices  
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Dispensing Devices  
Return or Disposal of Device  
• Unused devices will be returned to the 
sponsor at the end of the trial or if they 
expire 
• Contact the sponsor to obtain a RGA # 
(returned goods authorization number) 
• Log out the devices on the accountability log 
including the return date and Fed Ex number 
• If a device is discarded for any reason, this 
must also be entered into the device log 
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X  N/A 
 
Returned to sponsor, end of study 
RGA # 12556788 










X  N/A 
 
Device opened, contaminated, unused and 
discarded in the trash 
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Return or Disposal of Device 
Investigator Responsibilities 
• Control of the investigational device used in 
the study  
• Ensure the device is stored in a secure area 
• Ensure device is used only in patients that 
consented to participate in the trial 
• Ensure device is used according to the IRB-
approved protocol 
• Ensure records related to the receipt, use 
and disposition of the device are adequately 
maintained 
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